Clinical Trials Sponsored by Alar Irs

Total 956 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Schizophrenia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Observational Trial With Leios/Alesse

Contraceptives, Oral, Combined
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Prevenar in High-Risk Children

Pneumococcal Disease

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

Endometriosis | Dysmenorrhea | Pelvic Pain | Dyspareunia

Hong Kong, United States, Canada, Australia, United Kingdom, South Africa, Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

Meningitis, Meningococcal

Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose Study of SRA-444 in Healthy Subjects

Alzheimer Disease

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Vaccine in Adults With HIV

HIV Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

Diabetes Mellitus

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

Schizophrenia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy

Osteoarthritis | Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

Schizophrenia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

Diabetes Mellitus

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults

Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission

Depression
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.

Postmenopause | Postmenopausal Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Multi-Center Observational Surveillance Study of VAP Causing Bacteria

Ventilator Associated Pneumonia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause

Menopause

Belgium, Finland, Sweden, South Africa, Croatia, United Kingdom, France, Romania, Ukraine, Spain, Poland, Hungary, Czech Republic, Mexico, Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Effexor XR for Major Depression.

Depression

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.

Neoplasms | Tumors

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

Kidney Diseases | Kidney Failure

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

Menopause
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluation LXR-623 in Healthy Adults

Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients

Renal Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies

Osteoarthritis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

Ulcerative Colitis | Inflammatory Bowel Disease
Member Companies of the Opioid PMR Consortium
World Health Information Science Consultants, LLC; IMS Health

Completed

Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or Addiction

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Recruiting

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Ulcerative Colitis

United States, Spain, Japan, Belgium, Austria, Poland
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Terminated

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

Microvascular Obstruction

United States, Australia, Netherlands, Sweden, United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Graft vs Host Disease | Kidney Failure

Brazil
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Vaccines | Pneumococcal Conjugate Vaccine

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Alzheimer Disease

United States, Canada, South Africa, Argentina, Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

Schizophrenia

United States, France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

Alzheimer Disease | Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents

Allergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Arrhythmia

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution

Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

Endometriosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Vaccines, Pneumococcal

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Study of rhBMP-2/CPM in Closed Fractures of the Humerus

Fractures

France, Germany, Canada, United States, Australia, Mexico, Brazil, Finland, Norway, Romania, Sweden
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

Vaccines, Pneumococcal

Italy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa

Infant | Vaccines, Pneumococcal | Drug Therapy, Combination | Fever, Chemically Induced
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

Acute Myeloid Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

Clinical Trials Sponsored by Alar Irs

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations